Search

No relevant pages have been found.

No relevant news have been found: 5

Survival benefit of cetuximab for metastatic colorectal cancer

benefit of cetuximab for metastatic colorectal cancer... to KRAS mutation status in patients with metastatic colorectal cancer (mCRC), and found that the addition of Erbitux (cetuximab) to standard...

Phase 2 drug trial offers hope to patients with advanced colorectal cancer

N, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. The Lancet... metastatic colorectal cancer, survival...

Protein levels could predict if bowel cancer patients will benefit from Avastin

splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab. Clinical Cancer Research 2012. doi:...

Breast cancer gene provides vital clue to bowel cancer drug resistance

efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients. British Journal of Cancer 2013. doi:...

Research points to why some colorectal cancers recur after treatment

is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival. A... growth factor receptor (EGFR), metastatic colorectal cancer (mCRC), extracellular methylation,...

No centres with the requested content found.